Provider
Xolremdi (mavorixafor) - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Jan 01, 2025
Documents & Forms Results
Displaying 991 - 1000 of 3288 results
Provider
QP96-24 Prescription Drug Electronic Prior Authorization (ePA) Submission Process Update
Program effective Date: Dec 23, 2024
Provider
QP97-24 Commercial Pharmacy Benefit Exclusion for oxytocin, Pitocin® and Prepidil® Gel
Program effective Date: Dec 23, 2024
Provider
QP95-24 Commercial Pharmacy Benefit Exclusion for lanreotide, Ultomiris® and Visudyne®
Program effective Date: Dec 23, 2024
Provider
QP92-24 Process Update for Post-Acute Care Authorizations managed by eviCore Healthcare
Program effective Date: Dec 23, 2024
Provider
QP91-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective February 1, 2025
Program effective Date: Dec 23, 2024
Provider
QP90-24 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective January 1, 2025
Program effective Date: Dec 23, 2024
Provider
QP93-24 Blue Cross and Blue Shield of Minnesota Collaborating with Maven
Program effective Date: Dec 23, 2024
Provider
QP94-24 MHCP Pharmacy Benefit Exclusion for Darzalex Faspro®, Supprelin® LA and Visudyne®
Program effective Date: Dec 23, 2024